H
000627
vs
S
SLM
H
000627
S
SLM
Over the past 12 months, Hubei Biocause Pharmaceutical Co Ltd has underperformed SLM, delivering a return of -55% compared to the SLM's +10% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
000627
SLM
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
H
Intrinsic Value
5.07
CNY
Undervaluation 69%
S
SLM
Intrinsic Value
8 658.06
Zac
Overvaluation 3%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
1.58
CNY
|
|||||
|
S
|
Sanlam Ltd
JSE:SLM
|
8 891
Zac
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
000627, SLM
000627, SLM
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
H
|
Hubei Biocause Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
S
|
Sanlam Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
000627, SLM
000627, SLM
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
FCF is not applicable for financial companies
|
||||||||
|
S
|
Sanlam Ltd
JSE:SLM
|
FCF is not applicable for financial companies
|
||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Hubei Biocause Pharmaceutical Co Ltd
SLM
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd |
Not applicable for financial companies
|
|||
|
S
|
Sanlam Ltd |
Not applicable for financial companies
|
|||
Operating Margin
Hubei Biocause Pharmaceutical Co Ltd
SLM
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd |
Not applicable for financial companies
|
|||
|
S
|
Sanlam Ltd |
Not applicable for financial companies
|
|||
Net Margin
Hubei Biocause Pharmaceutical Co Ltd
-1.8%
SLM
12%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd | ||||
|
S
|
Sanlam Ltd | ||||
FCF Margin
Hubei Biocause Pharmaceutical Co Ltd
SLM
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd |
Not applicable for financial companies
|
|||
|
S
|
Sanlam Ltd |
Not applicable for financial companies
|
|||
ROE
Hubei Biocause Pharmaceutical Co Ltd
-3.6%
SLM
15.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd | ||||
|
S
|
Sanlam Ltd | ||||
ROA
Hubei Biocause Pharmaceutical Co Ltd
-0.3%
SLM
1.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd | ||||
|
S
|
Sanlam Ltd | ||||
ROIC
Hubei Biocause Pharmaceutical Co Ltd
SLM
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd |
Not applicable for financial companies
|
|||
|
S
|
Sanlam Ltd |
Not applicable for financial companies
|
|||
ROCE
Hubei Biocause Pharmaceutical Co Ltd
SLM
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd |
Not applicable for financial companies
|
|||
|
S
|
Sanlam Ltd |
Not applicable for financial companies
|
|||
Solvency Comparison
H
Hubei Biocause Pharmaceutical Co...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
000627, SLM
000627, SLM
Performance By Year
000627, SLM
000627, SLM
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 000627 to other stocks
DSY
Discovery Ltd
D
More expensive
vs Hubei Biocause Pharmaceutical...
601628
China Life Insurance Co Ltd
Cheaper
vs Hubei Biocause Pharmaceutical...
601318
Ping An Insurance Group Co of...
More expensive
vs Hubei Biocause Pharmaceutical...
OUT
OUTsurance Group Ltd
O
More expensive
vs Hubei Biocause Pharmaceutical...
Select Stock to Compare
| ZA |
S
|
Sanlam Ltd
JSE:SLM
|
|
| ZA |
D
|
Discovery Ltd
JSE:DSY
|
|
| CN |
|
China Life Insurance Co Ltd
SSE:601628
|
|
| CN |
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
|
| ZA |
O
|
OUTsurance Group Ltd
JSE:OUT
|
|
| HK |
|
AIA Group Ltd
HKEX:1299
|
|
| CA |
|
Manulife Financial Corp
TSX:MFC
|
|
| ZA |
O
|
Old Mutual Ltd
JSE:OMU
|
|
| US |
|
Aflac Inc
NYSE:AFL
|
|
| IN |
|
Life Insurance Corporation Of India
NSE:LICI
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
